Literature DB >> 7706329

Resection-shortening-distraction for malignant bone tumours. A report of two cases.

G Z Said1, E K el-Sherif.   

Abstract

We report two patients with malignant bone tumours treated by wide marginal resection in whom the residual bone defect was replaced by progressive distraction after allowing union to commence in the shortened position.

Entities:  

Mesh:

Year:  1995        PMID: 7706329

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  6 in total

1.  A novel approach to juxta-articular aggressive and recurrent giant cell tumours: resection arthrodesis using bone transport over an intramedullary nail.

Authors:  S Vidyadhara; Sharath K Rao
Journal:  Int Orthop       Date:  2006-05-25       Impact factor: 3.075

Review 2.  Intercalary reconstructions after bone tumor resections: a review of treatments.

Authors:  Georgios N Panagopoulos; Andreas F Mavrogenis; Cyril Mauffrey; Jan Lesenský; Andrea Angelini; Panayiotis D Megaloikonomos; Vasilios G Igoumenou; John Papanastassiou; Olga Savvidou; Pietro Ruggieri; Panayiotis J Papagelopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-06-05

3.  Current concepts of leg lengthening.

Authors:  Carol C Hasler; Andreas H Krieg
Journal:  J Child Orthop       Date:  2012-03-21       Impact factor: 1.548

4.  Two-stage surgical treatment for non-union of a shortened osteoporotic femur.

Authors:  Galal Zaki Said; Osama Ahmed Farouk; Hatem Galal Said
Journal:  Trauma Mon       Date:  2013-05-26

5.  Application of distraction osteogenesis in managing bone cysts.

Authors:  Vagif Verdiyev; Farhad Verdiyev
Journal:  J Orthop Traumatol       Date:  2013-10-16

6.  Reconstruction of Bone Defect Combined with Massive Loss of Periosteum Using Injectable Human Mesenchymal Stem Cells in Biocompatible Ceramic Scaffolds in a Porcine Animal Model.

Authors:  Chun-Cheng Lin; Shih-Chieh Lin; Chao-Ching Chiang; Ming-Chau Chang; Oscar Kuang-Sheng Lee
Journal:  Stem Cells Int       Date:  2019-11-23       Impact factor: 5.443

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.